Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;9(12):717-33.
doi: 10.1038/nrcardio.2012.145. Epub 2012 Oct 23.

Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy

Affiliations
Review

Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy

Changwon Kho et al. Nat Rev Cardiol. 2012 Dec.

Abstract

Cardiac myocyte function is dependent on the synchronized movements of Ca(2+) into and out of the cell, as well as between the cytosol and sarcoplasmic reticulum. These movements determine cardiac rhythm and regulate excitation-contraction coupling. Ca(2+) cycling is mediated by a number of critical Ca(2+)-handling proteins and transporters, such as L-type Ca(2+) channels (LTCCs) and sodium/calcium exchangers in the sarcolemma, and sarcoplasmic/endoplasmic reticulum calcium ATPase 2a (SERCA2a), ryanodine receptors, and cardiac phospholamban in the sarcoplasmic reticulum. The entry of Ca(2+) into the cytosol through LTCCs activates the release of Ca(2+) from the sarcoplasmic reticulum through ryanodine receptor channels and initiates myocyte contraction, whereas SERCA2a and cardiac phospholamban have a key role in sarcoplasmic reticulum Ca(2+) sequesteration and myocyte relaxation. Excitation-contraction coupling is regulated by phosphorylation of Ca(2+)-handling proteins. Abnormalities in sarcoplasmic reticulum Ca(2+) cycling are hallmarks of heart failure and contribute to the pathophysiology and progression of this disease. Correcting impaired intracellular Ca(2+) cycling is a promising new approach for the treatment of heart failure. Novel therapeutic strategies that enhance myocyte Ca(2+) homeostasis could prevent and reverse adverse cardiac remodeling and improve clinical outcomes in patients with heart failure.

PubMed Disclaimer

Conflict of interest statement

Competing interests

R. J. Hajjar declares an association with the following company: Celladon Corporation. See the article online for full details of the relationship. The other authors declare no competing interests.

Figures

Figure 1
Figure 1
Excitation–contraction coupling. During systole, the action potential depolarizes the sarcolemma. This depolarization enables a small amount of extracellular Ca2+ to enter the cytosol through the LTCCs. Ca2+ entry triggers the release of Ca2+ from the SR through RyR2 channels. The intracellular Ca2+ concentration increases and binding of Ca2+ to TN-C activates myofilaments, resulting in muscle contraction. Removal of cytosolic Ca2+ during diastole is primarily facilitated by SERCA2a, which returns Ca2+ to the SR. Some Ca2+ also exits the cell through NCX. The decrease in intracellular Ca2+ leads to dissociation of Ca2+ from TN-C and muscle relaxation. Abbreviations: LTCC, voltage-dependent L-type Ca2+ channel; NCX, Na+/Ca2+ exchanger; RyR2, ryanodine receptor 2; SERCA2, sarcoplasmic/endoplasmic reticulum calcium ATPase 2; SR, sarcoplasmic reticulum; TN-C, troponin C.
Figure 2
Figure 2
Abnormal intracellular Ca2+ handling in failing cardiomyocytes results in reduced contractile force and prolonged relaxation. a. Reduced SR Ca2+ storage and release cause abnormal systolic cardiomyocyte function. Abnormal β-AR and GPCR signaling increase the expression of PKA and CaMKII, which hyperphosphorylate and alter the function of RyR2 and LTCC. FKBP12.6 also contributes to stabilization of the RyR2 open probability. Impaired SERCA2a function decreases SR Ca2+ loading, resulting in reduced SR Ca2+ content and release and, therefore, reduced contractility. Alterations in LTCC function and STIM1–ORAI1-mediated store-operated Ca2+ influx can also result in abnormal Ca2+ handling during systole. b. Reduced SR Ca2+ resequestration is a key abnormality in diastole. Decreased SERCA2a activity, downregulation of SERCA2a, a decreased PLB:SERCA2a ratio, or PLB hypophosphorylation cause prolonged intracellular Ca2+ transients, reduced SR Ca2+ loading, and slowed cardiomyocyte relaxation. An increase in levels of NCX might be a compensatory response to prevent Ca2+ overloading. While increased NCX activity would be initially adaptive, excessive or sustained NCX activation could contribute to decreased sarcoplasmic reticulum Ca2+ content by removing cytosolic Ca2+, and reducing systolic Ca2+ transients and contractile function. SR Ca2+ leak resulting from impaired RyR2 function and increased expression of PP1 can reduce SR Ca2+ content and increase cytosolic Ca2+ concentration during diastole. On activation, the β-AR–AC–GPCR complex synthesizes cAMP, which activates PKA. Hyperactive PKA decreases the Ca2+ sensitivity of the myofilaments and prolongs relaxation. Intracellular Ca2+ overload stimulates CaMKII, which contributes to SR diastolic Ca2+ leak by hyperphosphorylating RyR2 and induces the transduction of pathological Ca2+ signaling. Abbreviations: AC, adenylate cyclase; β-AR, β-adrenergic receptor; CaMKII, calcium and calmodulin-dependent protein kinase type II; FKBP12.6, FK506 binding protein; GPCR, G-protein-coupled receptor; LTCC, voltage-dependent L-type Ca2+ channel; NCX, Na+/Ca2+ exchanger; Orai-1, calcium-release activated calcium channel protein 1; P, phosphorylation; PLB, cardiac phospholamban; PP1, protein phosphatase 1; RyR2, ryanodine receptor 2; SERCA2a, sarcoplasmic/endoplasmic reticulum calcium ATPase 2a; STIM1, stromal interaction molecule 1.

References

    1. de Giuli F, et al. Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail. 2005;7:295–302. - PubMed
    1. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005;112:3577–3583. - PubMed
    1. Jiang H, Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart. 2009;95:1727–1731. - PubMed
    1. Clapham DE. Calcium signaling. Cell. 1995;80:259–268. - PubMed
    1. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11–21. - PubMed

Publication types